STOCKWATCH
·
Pharmaceutical Preparations
Corporate ActionMay 1, 2026, 04:41 PM

Veradermics Raises $414.4M via Public Offering & Private Placement

AI Summary

Veradermics, Inc. successfully closed a public offering and a concurrent private placement, raising approximately $414.4 million in gross proceeds. The public offering involved 3,843,790 common shares at $100.00 per share, with an option for underwriters to purchase additional shares. Concurrently, the company sold 300,000 pre-funded warrants to Suvretta Capital affiliates at $99.99999 per warrant, generating $30.0 million. These capital raises are expected to provide significant funding for the company's operations.

Key Highlights

  • Closed public offering of 3,843,790 common shares at $100.00 per share.
  • Gross proceeds from public offering approximately $384.4 million.
  • Granted underwriters 30-day option to purchase up to 576,568 additional shares.
  • Closed private placement of 300,000 pre-funded warrants at $99.99999 per warrant.
  • Gross proceeds from private placement approximately $30.0 million.
  • Private placement investors affiliated with Suvretta Capital.
  • Pre-funded warrants exercisable at $0.00001 per share, with no expiration.
  • Company agreed to certain issuance restrictions for 90 days post-agreement.
MANE
Pharmaceutical Preparations
Veradermics, Inc

Price Impact